Rajendra Nath

Prof. Rajendra Nath

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2016 in Neurological Research
Verified
Journal Article
Closed access
RPRishi Pal
Rishi Pal
PTPrafulla Chandra Tiwari
Prafulla Chandra Tiwari
RNRajendra Nath
Rajendra Nath
KPKamlesh Kumar Pant
Kamlesh Kumar Pant
Parkinson’s disease (PD) the second most common age-associated progressive neurodegenerative disorder is characterized by loss of dopaminergic neurons, cytoplasmic inclusions of aggregated proteins (Lewy bodies), and neuroinflammation. The inflammation of neurons causes release of various inflammatory mediators (IFNs, EGF, IL5, IL6, HGF, LIF and BMP2). The hallmarks of neuroinflammation are the presence of activated microglia and reactive astrocytes in the parenchyma of the CNS and increased production of cytokines, chemokines, prostaglandins, complement cascade proteins, and reactive oxygen and nitrogen species (ROS/RNS) which in some cases can result in disruption of the blood brain barrier and direct participation of the adaptive immune system. Latent transcription factors such as NF-κB, STAT 3, AP1, and SMAD 7, Toll like receptors and FAF 1 are constitutively upregulated in activated microglia. Toll-like receptors when activated promote NF-κB signaling thus promoting a vicious cycle of neuroinflammation. These transcription factors take dopaminergic neurons to apoptotic pathway via p53 and other death domain receptors. Neuroprotective signaling pathways such as mTOR, SOCS, and TGF-β down regulated during development of PD. YY1 signaling, which has protective effect against α-Synuclein toxicity, is significantly decreased in PD patients. In summary we can say that transcription factors promoting inflammation such as NF-κB, STAT 3, AP 1, and Toll-like receptors are constitutively upregulated in PD, while neuroprotective pathways such as mTOR, TGF-β, and YY1 are substantially downregulated in microglia of PD patients.

18 October 2017 in Annals of Neurosciences
Verified
Journal Article
Open access
PDF file
PSPramod Kumar Singh
Pramod Kumar Singh
MSManish Kumar Singh
Manish Kumar Singh
RYRajesh Singh Yadav
Rajesh Singh Yadav
RDRakesh Kumar Dixit
Rakesh Kumar Dixit
AMAnju Mehrotra
Anju Mehrotra
RNRajendra Nath
Rajendra Nath
Background: Lead is widely distributed in the environment and has been found to be associated with various health problems including neurodegenerative diseases. Purpose: In view of the increasing health risk caused by lead, this study has been carried out to investigate the neuroprotective effect of omega-3 fatty acid (omega-3FA) in lead-induced neurotoxicity in rats. Methods: Biochemical parameters including oxidative stress in brain regions, lead levels in blood and brain regions and histopathological examination of brain regions of rats were carried out in the present study. Results: Rats exposed to lead (lead acetate 7.5 mg/kg body weight p.o. for 14 days) caused a significant increase in the levels of lipid peroxidation, protein carbonyl content, ROS production and decreased the activities of glutathione peroxidase, superoxide dismutase and catalase in the cerebellum and cerebral cortex, respectively, as compared to controls. Abnormal histopathological changes and increase in the levels of lead in blood and brain were also observed as compared to controls. Co-treatment of lead with omega-3FA (750 mg/kg body weight p.o. for 14 days) decreased the levels of lipid peroxidation, protein carbonyl content, ROS production and increased the activities of glutathione peroxidase, superoxide dismutase and catalase and showed protection in the histopathological study as compared to rats treated with lead alone. Conclusions: The result of the present study shows that lead-induced oxidative stress and histopathological alteration in the brain region were significantly protected with co-treatment of lead and omega-3FA. This could be due to its strong antioxidant potential and metal-binding property.

1 August 2015 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
HAHarshika Awasthi
Harshika Awasthi
RNRajendra Nath
Rajendra Nath
KUKauser Usman
Kauser Usman
DMDayanandan Mani
Dayanandan Mani
SKSanjay Khattri
Sanjay Khattri
KSKamal Kumar Sawlani
Kamal Kumar Sawlani

31 July 2017 in Nutritional Neuroscience
Verified
Journal Article
Closed access
PSPramod Kumar Singh
Pramod Kumar Singh
MSManish Kumar Singh
Manish Kumar Singh
RYRajesh Singh Yadav
Rajesh Singh Yadav
RNRajendra Nath
Rajendra Nath
AMAnju Mehrotra
Anju Mehrotra
RDRakesh Kumar Dixit
Rakesh Kumar Dixit
Objectives: In view of the increasing risk of lead on human health, the present study has been carried out to investigate the neuroprotective effect of omega-3 fatty acid on chronic lead-induced neurotoxicity and behavioral impairment in rats. Methods: Different neurobehavioral parameters, biochemical assays, and histopathological analyses in brain regions of rats were conducted. Results: Rats exposed to different doses of lead (lead acetate 2.5, 5.0, 7.5 mg/kg body weight p.o. for 90 days) caused a significant decrease in body weight, brain weight, and behavioral changes as compared to controls. Abnormal histopathological and increased levels of lead in blood and brain regions increased the levels of ROS, LPO, PCC and decreased the levels of GSH with concomitant reduction in SOD, CAT, and GPx activities in the brain region of rats treated with different doses of lead as compared to controls. Co-treatment of lead with omega-3 fatty acid (500 mg/kg body weight p.o. for 90 days) decreased the levels of ROS, LPO, PCC, and increased the level of GSH, also increased SOD, CAT, and GPx activity and showed improvements in behavioral as well as histopathological changes as compared to lead-treated groups. Discussion: Our results proved that omega-3 fatty acid improved behavioral deficits, altered histopathological and oxidative stress in lead-intoxicated rats. Among three different doses, 2.5 mg/kg b.wt. of lead along with omega-3 fatty acid was the most preventive dose for the neurotoxicity. This work reveals the potential of omega-fatty acid as a protective drug for lead neurotoxicity.

19 December 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
VMVineet Malhotra
Vineet Malhotra
SPSeema R. Pathak
Seema R. Pathak
RNRajendra Nath
Rajendra Nath
DMDevashish Mukherjee
Devashish Mukherjee
KSK. Shanker
K. Shanker

20 November 2014 in Central Nervous System Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SPSeema R. Pathak
Seema R. Pathak
VMVineet Malhotra
Vineet Malhotra
RNRajendra Nath
Rajendra Nath
KSKripa Shanker
Kripa Shanker
A series of novel substituted quinazolin-4(3H)-one derivatives were synthesized and screened in vivo for their antihypertensive activities. Out of eighteen synthesized compounds, seven i.e. 2a, 2c, 4a, 4d, 5d, 6a & 6b compounds have shown hypotensive effect and produced bradycardia. These compounds have shown better activity than reference drug Prazosin (which acts as anti-hypertensive agent by α1 blocking action). All the compounds have shown ALD50>1000mg/kg with maximum in 2c & 4d (>1200mg/kg).